Developing a nationwide infrastructure for therapeutic drug monitoring of targeted oral anticancer drugs: the ON-TARGET study protocol
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Cancers (2021) 13:24, 6281. https://doi.org/10.3390/cancers13246281
- Event
-
Veröffentlichung
- (where)
-
Würzburg
- (who)
-
Universität Würzburg
- (when)
-
2022
- Creator
-
Mc Laughlin, Anna M.
Schmulenson, Eduard
Teplytska, Olga
Zimmermann, Sebastian
Opitz, Patrick
Groenland, Stefanie L.
Huitema, Alwin D. R.
Steeghs, Neeltje
Müller, Lothar
Fuxius, Stefan
Illerhaus, Gerald
Joerger, Markus
Mayer, Frank
Fuhr, Uwe
Holdenrieder, Stefan
Hempel, Georg
Scherf-Clavel, Oliver
Jaehde, Ulrich
Kloft, Charlotte
- DOI
-
10.3390/cancers13246281
- URN
-
urn:nbn:de:bvb:20-opus-252196
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:51 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mc Laughlin, Anna M.
- Schmulenson, Eduard
- Teplytska, Olga
- Zimmermann, Sebastian
- Opitz, Patrick
- Groenland, Stefanie L.
- Huitema, Alwin D. R.
- Steeghs, Neeltje
- Müller, Lothar
- Fuxius, Stefan
- Illerhaus, Gerald
- Joerger, Markus
- Mayer, Frank
- Fuhr, Uwe
- Holdenrieder, Stefan
- Hempel, Georg
- Scherf-Clavel, Oliver
- Jaehde, Ulrich
- Kloft, Charlotte
- Universität Würzburg
Time of origin
- 2022
Other Objects (12)
New anticancer drugs
Targeted drug delivery
Evaluation of targeted anti-cancer drugs for the treatment of aggressive meningiomas
Riboflavin-Targeted Drug Delivery
Neurological adverse reactions to anticancer drugs
Human tumour xenografts in anticancer drug development
Molecular aspects of anti-cancer drug action
Relevance of tumor models for anticancer drug development
Metallo-Drugs: development and action of anticancer agents
Machine learning-based anti-cancer drug treatment optimization
Cisplatin : chemistry and biochemistry of a leading anticancer drug
Supramolecular metallocages as potential delivery systems for anticancer drugs
New anticancer drugs
Targeted drug delivery
Evaluation of targeted anti-cancer drugs for the treatment of aggressive meningiomas
Riboflavin-Targeted Drug Delivery
Neurological adverse reactions to anticancer drugs
Human tumour xenografts in anticancer drug development
Molecular aspects of anti-cancer drug action
Relevance of tumor models for anticancer drug development
Metallo-Drugs: development and action of anticancer agents
Machine learning-based anti-cancer drug treatment optimization
Cisplatin : chemistry and biochemistry of a leading anticancer drug
Supramolecular metallocages as potential delivery systems for anticancer drugs
New anticancer drugs
Targeted drug delivery
Evaluation of targeted anti-cancer drugs for the treatment of aggressive meningiomas
Riboflavin-Targeted Drug Delivery
Neurological adverse reactions to anticancer drugs
Human tumour xenografts in anticancer drug development
Molecular aspects of anti-cancer drug action
Relevance of tumor models for anticancer drug development
Metallo-Drugs: development and action of anticancer agents
Machine learning-based anti-cancer drug treatment optimization
Cisplatin : chemistry and biochemistry of a leading anticancer drug